| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Aug 7, 2025 | RGA Investment Advisors | - | - | AVGO, AWE.L, CRSP, FEVR.L, MTN, PTON, PYPL, ROKU, WDAY | Biotechnology, conviction, Enterprise Software, Fitness, Streaming, Trade Policy, volatility | CRISPR Therapeutics represents a first-mover advantage in cell and gene therapy with commercial approval of Casgevy. The company trades at a significant discount with strong cash position and pipeline optionality. Management has balanced capital discipline with R&D ambition, positioning the company to lean into its pipeline while competitors retrench. | MTN AWE PYPL FEVR ROKU WDAY PTON CRSP |
View |
| 2025 Q2 | Aug 18, 2025 | Bonsai Partners | - | 7.3% | AMZN, CELH, FEVR.L, KO, MNST, TAP, WISE.L | Beverages, Customer Focus, Distribution, Enduring Economics, Partnerships, Quality | Fever-Tree demonstrates the power of premium positioning in the mixer industry, capitalizing on Schweppes' fragmented ownership structure. The company's partnership with Molson Coors provides guaranteed minimum royalty payments through 2030, offering strong earnings visibility and resolving margin issues through domestic manufacturing. | FEVR.L |
View |
| 2025 Q2 | Jul 15, 2025 | Highwood Value Partners | - | 4.2% | ALIM.ST, BOL.PA, BORR.OL, BUR.L, FEVR.L, GETB.L, HFG.DE, JZCP.L, MOTR.L, PROT.OL, RYA.L, TRI.PA | Beverages, Europe, insurance, small caps, SMID Cap, Travel, value | Highwood focuses on finding great businesses at attractive prices trading at significant discounts to intrinsic value. The portfolio trades at 48 cents on the dollar of estimated intrinsic value with a median P/E of 7.6x. The firm's research identified that international small and mid-cap companies have been the happy hunting ground for value investors, with European companies showing the highest base rates for delivering 4x returns. | TRI.PA BORR HFG BOL BUR LN JZCP LN MOTR LN FEVR LN PROT NO TRI FP |
View |
| 2025 Q2 | Jul 1, 2025 | Langdon Global Smaller Companies | 10.5% | 10.5% | AGYS, AND.TO, FEVR.L, JLG.AX, TOI.TO | global, healthcare, industrials, Quality, small caps, technology, value | The manager sees attractive opportunities in industrial software and highlights Agilysys as benefiting from structural modernization trends in hospitality. Their software platform is becoming mission-critical for hotels and casinos upgrading property management systems, with the company still in early innings of capturing wallet share globally. | FEVR.L CHA.DE TOI.TO ATG.L AHG.TO AGYS JLG.AX |
View |
| 2024 Q1 | May 9, 2024 | Polen Capital – Global SMID Company Growth | 7.4% | -2.4% | 3697.T, 8069.TWO, CNM, CWAN, DAVA, EVD.L, FEVR.L, GLOB, JDG.L, PME.AX, REVG, TOI.TO, WIZZ.L | global, growth, infrastructure, IT Services, Quality, SMID Cap, software | The portfolio holds multiple IT services companies including Globant and Endava, both facing headwinds from cautious client spending on digital transformation. Despite near-term challenges, the managers maintain confidence in long-term secular trends driving digital transformation and AI integration. | 3697.T DAVA GLOB CNM EVD.DE TOI.TO |
View |
| 2025 Q1 | May 12, 2025 | Langdon Global Smaller Companies | 0.0% | - | 4658.T, AND.TO, DAL.L, ENX.PA, FEVR.L, JLG.AX, RBREW.CO, SKWD, WOSG.L, YETI | consumer, global, private markets, small caps, tariffs, value, volatility | Manager emphasizes the small cap universe is 10x the size of large caps, providing abundant opportunity. Despite weak IPO activity over the past three years, approximately 1,750 companies have still come to market. The fund maintains focus on building a collection of durable, value-creating businesses that can deliver strong absolute returns across market environments. | View | |
| 2025 Q3 | Oct 28, 2025 | Graham and Doddsville | - | - | AAON, AAP, ANET, AOS, ASTS, CVNA, DLO, FEVR.L, GOOGL, KER.PA, MELI, META, NLB.L, PGR, RKLB, TBCG.L, TSM, WISE.L, WOSG.L, XPEL | AI, emerging markets, Investment Analysis, long-term, Portfolio Management, Quality, Student Pitches, Value Investing | Multiple interviews emphasize value investing principles, with Brandes Investment Partners maintaining pure value philosophy despite 165 months of underperformance following the global financial crisis. The publication showcases various value-oriented approaches from concentrated portfolios to systematic value investing strategies. | View | |
| 2024 Q3 | Oct 23, 2024 | Langdon Global Smaller Companies | 9.0% | 16.7% | CSWI, DQ, ESQ, FEVR.L, GSHD, HEINY, JLG.AX, MEDP, NVDA, ROYAL.CO, YETI | Europe, global, Research, small caps, software, Travel | The manager spent 2+ months in Lyon, France testing an extended stay approach to investment research, conducting dozens of meetings across Western Europe. This 'invest like a local' philosophy involves understanding local context through extended presence rather than brief hotel-based visits. | ALSK.PA YETI |
View |
| 2024 Q3 | Oct 18, 2024 | Polen Capital – Global SMID Company Growth | 7.4% | -2.4% | 8112.HK, ALIT, BLD, CWAN, ELF, EXLS, FEVR.L, FIVE, GSHD, KNSL, MPWR, PGNY, REVG, TECH, TME, TTEK | global, growth, portfolio, Quality, SMID Cap | Polen focuses on high-quality companies with solid fundamentals, competitive advantages, and strong business models. The managers emphasize their disciplined approach to selecting companies that meet high hurdles for growth and returns. They maintain conviction in their quality growth-oriented portfolio despite recent volatility. | View | |
| 2025 Q3 | Oct 1, 2025 | Vela International Fund | 7.4% | - | AGI.TO, ALLFG.L, ARCO, ARGX, BAP.AX, COA.L, FEVR.L, FIE.DE, FUC.DE, GLOB, HIK.L, IFX.DE, INDV.L, JEL.HK, KRKA.L, NOMD.L, OGC, SRP.L, TECN.SW, WIE.VI | Cash, gold, healthcare, international, tariffs, value | Gold serves as insurance against credit destruction and declining confidence in financial authorities. Current environment supports gold due to high US debt levels, potential Federal Reserve independence threats, and geopolitical tensions from Russia sanctions. Gold miners provide leveraged exposure with focus on low-risk jurisdictions and organic growth. | GLOB COA LN FEVR LN TECN SW HIK LN |
View |
| 2024 Q4 | Jan 30, 2025 | Langdon Global Smaller Companies | 3.6% | 19.8% | ATG.L, ESQ, FEVR.L, GSHD, RBREW.DC, SFE.L, SKWD, WOSG.L | Beverages, global, insurance, private credit, small caps, value | Westaim's successful exit from Skyward Specialty Insurance delivered approximately 2.5-3x multiple of capital with 13% gross annualized return. CC Capital's investment brings insurance platform expertise to create an insurance-led asset management model similar to Apollo/Athene and Ares/Aspida. | RBREW.DC FEVR.L WED.TO |
View |
| 2025 Q4 | Jan 20, 2026 | Highwood Value Partners | 5.7% | 10.2% | 2333.HK, ALIM-B.ST, BOL.PA, BORR, BUR.L, FEVR.L, GETB.L, JZC.L, MOT.L, ODET.PA, PROT.OL, RYA.L, STDRL.OL, SYY, TAP, TGO.PA, UMG.AS, VIV.PA, VWS.CO | Capital Cycle, Concentration, energy, Europe, Litigation Finance, special situations, value | Manager emphasizes concentrated value investing approach, buying companies at significant discounts to fair value. Portfolio trades at 48 cents on the dollar of estimated intrinsic value with median P/E of 7.5x. Focus on fundamental bottom-up analysis with 5+ year holding periods. Burford Capital represents the largest position as a litigation finance leader. The business generates returns by funding commercial litigation claims and managing third-party capital. YPF case represents major catalyst with clear judgment in favor. Borr Drilling is a special situation in shallow water drilling rigs. The capital cycle investment thesis centers on industry oversupply working through the system, with rig rates recovering from current levels toward long-run averages as old rigs retire. | RYAAY FEVR LN GETB LN BORR NO BUR LN |
View |
| 2024 Q4 | Jan 23, 2025 | Polen Capital – Global SMID Company Growth | 7.4% | -2.4% | 8112.T, ALIT, BLD, CWAN, ELF, EXLS, FEVR.L, FIVE, GSHD, KNSL, MPWR, PGNY, REVG, TECH, TME, TTEK | global, growth, Quality, SMID Cap, underperformance, volatility | Initiated position in elf Beauty, a cosmetics company with reputation for quality and innovation at considerably lower prices than other mass cosmetics brands. The company has robust growth potential with low brand awareness, expanding shelf space, growing product portfolio, and early international expansion opportunities. | View | |
| 2024 Q4 | Jan 15, 2025 | Highwood Value Partners | - | 4.6% | ALIM.ST, BOL.PA, BORR, BUR.L, FEVR.L, GETB.L, HFG.DE, JZCP.L, MOTR.L, PROT.OL, RYA.L | Europe, Long Term, Quality, SMID Cap, valuation, value | Manager emphasizes buying great businesses at attractive valuations as the core investment approach. Portfolio trades at 0.47x intrinsic value with median P/E of 8.1x versus US markets at historically high valuations. European markets offer compelling value opportunities with select markets at all-time low valuations. | HFG.DE FEVR.L |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Fund Letters | Langdon Global Smaller Companies | Fever-Tree | Consumer Staples | Soft Drinks | Bull | LSE | asset-light, Brand Marketing, Joint venture, Molson Coors, Premium Mixers, turnaround, UK | View Pitch |
| Apr 13, 2026 | Fund Letters | Bonsai Partners | Fever-Tree Drinks | Consumer Staples | Soft Drinks | Bull | London Stock Exchange | asset-light, Beverage, Brand, consumer staples, Distribution Partnership, Margin recovery, Premium Mixers, royalty model, supply chain, turnaround, UK | View Pitch |
| Apr 13, 2026 | Fund Letters | Highwood Value Partners | Fever-Tree Drinks PLC | Consumer Staples | Soft Drinks | Bull | London Stock Exchange | Branded Consumer, debt-free, Europe, founder-led, Ginger Beer, M&A Target, Margin recovery, Mixers, Premium Beverages, Tonic Water, turnaround, UK, US | View Pitch |
| Apr 13, 2026 | Fund Letters | Langdon Global Smaller Companies | Fevertree Drinks PLC | Consumer Staples | Soft Drinks | Bull | LSE | Beverages, consumer staples, defensive, Margin recovery, Premium Mixers, Revenue Growth, UK, valuation discount, Value | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||